A Study of RNK08954 in Subjects With Advanced Solid Tumors With KRAS ((Kirsten Rat Sarcoma) G12D Mutation
Clinical trial NCT06667544 · RECRUITING
Trial details
- NCT number
- NCT06667544
- Sponsor
- Ranok Therapeutics (Hangzhou) Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-08
- Primary completion
- 2026-12-01
- Enrollment
- 152
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.